<p>Rapid and ongoing improvement in patient symptoms, with 57% median best improvement on MC-QoL and 78% of patients reporting ≥1 point improvement on PGIS by week 20 100% of bezuclastinib treat
<p><strong>Overnight Headlines</strong></p> <p>*USD ended the day modestly lower, closing at 92.62</p> <p>*US stocks retreated from record highs amid mixed da
Leave a Comment